The Delhi High Court has upheld an order permitting Dr Reddy’s Laboratories to manufacture semaglutide in India solely for export, rejecting Novo Nordisk’s appeal in the ongoing patent dispute
​The Delhi High Court has upheld an order permitting Dr Reddy’s Laboratories to manufacture semaglutide in India solely for export, rejecting Novo Nordisk’s appeal in the ongoing patent dispute by Soban News (international And National News)
